Register Login
Register to leave comments
  • News bot Sept. 1, 2026, 8:32 p.m.

    📋 POLARYX THERAPEUTICS, INC. (PLYX) - Clinical Trial Update

    Filing Date: 2026-09-01

    Accepted: 2026-09-01 16:30:15

    Event Type: Clinical Trial Update

    Event Details:

    POLARYX THERAPEUTICS, INC. (PLYX) Announces Clinical Trial Update POLARYX THERAPEUTICS, INC. (PLYX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: initiation
    • Diseases/Conditions: senior clinical development roles
    • Clinical Stage: Phase 2, clinical trial
    • Collaboration: Tyra Biosciences
    • Updated Timeline: Q4 2026

    🔬 Clinical Development Pipeline (POLARYX THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    PLX-200 Other Phase PHASE3 Juvenile Neuronal Ceroid Lipofuscinosis ClinicalTrials.gov
    Placebo Other Phase PHASE3 Juvenile Neuronal Ceroid Lipofuscinosis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: POLARYX THERAPEUTICS, INC.
    • Ticker Symbol: PLYX

Search

News categories